(Omron andMedtronicSigning Ceremony, Source: Photo provided by the company)
With the acceleration of aging and the pace of life, the population suffering from chronic diseases is increasing year by year and showing a trend of becoming younger. In recent years, the prevalence of diabetes and hypertension has been continuously rising. Data shows that the population with diabetes in China exceeds 100 million, with a prevalence rate of over 10%. The number of adults with hypertension is about 245 million, with a prevalence rate of 27.9%.
Why? The systematic construction of chronic disease management systems is the solution provided by Omron.
Recently, Omron announced that it hasMedtronicReach a Strategic Cooperation in Hypertension Patient Screening and Management: Both Parties to Deepen Collaboration in Hypertension Screening and Management, and Synergistically Develop in Areas Such as Interventional Diagnosis and Treatment. Omron to Leverage Its Channel Strengths and Other Advantages.MedtronicProvide global medical technology, services, and solutions.
Omron Pavilion, Photo provided by the company
According to the APP of Titanium Media, in order to better solve the problem of chronic disease management, Omron will cooperate withMedtronicExplore innovative management systems, incorporating nighttime blood pressure monitors into the daily blood pressure monitoring of patients before and after RDN procedures.
During the day, patients can complete blood pressure measurements through active monitoring; at night, patients can complete timed monitoring in their sleep by pre-setting; doctors can observe the blood pressure changes before and after the patient's surgery through multi-point blood pressure data measured throughout the day, and evaluate the treatment effect.
Notably, this is Omron's second collaboration withMedtronicCooperation: One year ago, the two parties reached a cooperation in building a cardiac screening and treatment system, and have achieved phased results in atrial fibrillation ablation and cardiac rhythm fields.
"Actually, we andMedtronic"We started the negotiation in 2021. At that time, we wanted to develop a new product with atrial fibrillation screening function, which involved more cardio-cerebrovascular fields. A company's ability is limited, so we wanted to cooperate with partners who have a common vision to rebuild atrial fibrillation screening in China," said Jin Jiacheng, Director of Omron's Business Planning Division, to Titanium Media APP.
According to the introduction, starting from June this year, Omron has collaborated withMedtronicJointly conducted multiple patient education and free clinics in Nanjing, Jiangsu; Wuhan, Hubei; Guiyang, Guizhou; Urumqi, Xinjiang, and other places, targeting patients with atrial fibrillation and arrhythmia, committed to raising public awareness of cardiovascular health.
"In pharmacies and other scenarios, we have gathered many patients with blood pressure issues. We use our blood pressure monitors to check for the possibility of atrial fibrillation (AFib). The screening and awareness of AFib are quite important as it can lead to diseases such as stroke or heart attack," Jin Jiazheng told the Titanium Media App.
In addition, the two parties have also established a pilot program for atrial fibrillation screening and referral pathway construction at hospitals in Jiangsu Province, scientifically standardizing the diagnosis and treatment of cardiovascular diseases, and building a healthy ecosystem for cardiovascular disease education, prevention, and treatment.
So far, Omron's blood pressure-related products include electronic blood pressure monitors with atrial fibrillation detection prompts, electrocardiogram-integrated blood pressure monitors, watch-style blood pressure monitors, nighttime wrist blood pressure monitors, and irregular pulse wave monitoring blood pressure monitors. It is reported that it has been 50 years since the release of Omron blood pressure monitors. Omron blood pressure monitor products are available in more than 130 countries and regions around the world, with cumulative global sales exceeding 350 million units.（This article was first published in TMT (Titanium Media)APP，Author | Zhang HaixiaYang Yaru）